business
COMPANY BENCHMARKING • UNITED STATES

CH Boehringer Sohn AG & Ko. KG - Company Profile

Access all 5,000+ company profiles through the Benchmarking Pro Membership. Unlock interactive competitor comparison tools that show you how CH Boehringer Sohn AG & Ko. KG stacks up to the competition and put relevant competitor and industry information at your fingertips.


CH Boehringer Sohn AG & Ko. KG - Overview

Brands
Boehringer Ingelheim, Merial Limited
Description
CH Boehringer Sohn is a private company with an estimated 52,000 employees. In the US, the company has a notable market share in at least one industry: Brand Name Pharmaceutical Manufacturing, where they account for an estimated 2.5% of total industry revenue.
Company Details

Registered Name: CH Boehringer Sohn AG & Ko. KG

Company Type: Other

Employees: 52000

CH Boehringer Sohn AG & Ko. KG - Operating Industries and Main Competitors

error_outline To view all of CH Boehringer Sohn AG & Ko. KG's operating industries and competitors, see purchase options.

CH Boehringer Sohn AG & Ko. KG - Products and Services

  • Brand Name Pharmaceutical Manufacturing in the US

    • Of the 8 core revenue-generating products and services in the Brand Name Pharmaceutical Manufacturing in the US industry, CH Boehringer Sohn AG & Ko. KG offers:
    • Autoimmune prescriptions
    • Cardiovascular prescriptions
    • Diabetes prescriptions
    • AAAAA AAAAA
error_outline To view CH Boehringer Sohn AG & Ko. KG's full products and services, see purchase options.

CH Boehringer Sohn AG & Ko. KG - Analyst Insights

Company launches biopharmaceutical production facility in Vienna, Austria

In 2021, the company opened a state state-of-the-art biopharmaceutical production in Vienna, Austria. At a cost of nearly $800.0 million, the facility represents the single largest investment in the company's history. The facility adds 185,000 liters of biopharmaceutical production capacity and is one of the most advanced of its kind, ensuring a high degree of digitalization and automation through smart technologies and artificial intelligence applications. The Large Scale Cell Culture (LSCC) facility is expected to create 500 new jobs in Vienna.

COVID|Balance Sheet|New Activity|ESG


In response to volatile demand in the wake of the first COVID-19 surge, the company undertook a comprehensive cost reduction program, aimed at shoring up labor and supply costs.

Lorem Ipsum text header Report Title

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Maecenas non leo lacinia, consectetur ipsum non, pretium augue. Vestibulum accumsan dignissim massa, eu scelerisque mi malesuada ut. Aliquam scelerisque facilisis nisl ac varius. Nunc luctus nunc vel eros iaculis, vitae tristique ante fringilla. Ut vitae vulputate est, vel lacinia nisi. Curabitur eget nulla vitae mi faucibus imperdiet. Cras sagittis arcu eu diam pharetra iaculis eget sit amet risus. Morbi eget turpis ut diam commodo congue id eu lacus.

Cras sagittis arcu eu diam pharetra iaculis eget sit amet risus. Morbi eget turpis ut diam commodo congue id eu lacus.

error_outline To view all analyst insights on CH Boehringer Sohn AG & Ko. KG, see purchase options.

CH Boehringer Sohn AG & Ko. KG - SWOT Analysis

Strengths and weaknesses take into account internal factors, and are based on CH Boehringer Sohn AG & Ko. KG's performance in comparison to its competitors. Opportunities and Threats focus on external influences, and are based on trends and demand in the Brand Name Pharmaceutical Manufacturing in the US industry.
Strengths
Days Receivables: x.x%
Purchase a membership to unlock the full SWOT analysis of this company.
lock
Rank: 2 of 3 peers
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
Annual Turnover: x.x%
Purchase a membership to unlock the full SWOT analysis of this company.
lock
Rank: 2 of 3 peers
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
Weaknesses
Credit Risk: x.x%
Purchase a membership to unlock the full SWOT analysis of this company.
lock
Rank: 2 of 3 peers
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
Revenue per Employee: $xx
Purchase a membership to unlock the full SWOT analysis of this company.
lock
Rank: 2 of 3 peers
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
Opportunities
  • AAAAA
  • AAAAA
  • AAAAA
Threats
  • AAAAA
  • AAAAA
  • AAAAA

error_outline To view CH Boehringer Sohn AG & Ko. KG's full SWOT analysis, see purchase options.

CH Boehringer Sohn AG & Ko. KG - Financial Statements & Ratios

pie_chartCH Boehringer Sohn AG & Ko. KG Income Statement

BALANCE DATE12/31/2022
Revenue24,000.0
Cost of Revenue0000
Cost of Revenue, Non-Cash0000
Gross Profit0000
AAAAAA AAAAAA0000

pie_chartCH Boehringer Sohn AG & Ko. KG Balance Sheet

BALANCE DATE12/31/2022
Cash and EquivalentsN/A
Short-Term Investments0000
Derivative Assets, Current0000
Restricted Cash and Investments0000
AAAAAA AAAAAA0000

pie_chartCH Boehringer Sohn AG & Ko. KG Cash Flow

BALANCE DATE12/31/2022
Net IncomeN/A
Income (Loss) From Discontinued Operations0000
Depreciation, Depletion and Amortization0000
Amortization of Financing Costs and Discounts0000
AAAAAA AAAAAA0000

error_outline To view all financial data for CH Boehringer Sohn AG & Ko. KG, see purchase options.

GET INSTANT ACCESS WITH BENCHMARKING PRO MEMBERSHIP

100% Money Back Guarantee Digicert Trusted

BENCHMARKING PRO

What's Inside
Benchmarking Pro?

A suite of company and industry data that:

Benchmarks companies against industry averages or like-sized segments, as well as close competitors
Identifies real-world strengths, opportunites, weaknesses and threats
Reveals growth opportunities or red flags in a business growth strategy
LEARN MORE

Included in Report

  • Enterprise History & Synopsis
    Enterprise History & Synopsis
  • Enterprise Financial Statements
    Company Financial Statements
  • Financial Ratios
    Industry Market Share Breakdown
  • Industry Averages
    Industry Competitor Matrix
  • Competitive Landscape
    SWOT Analysis
  • Key Enterprise Personnel
    Products and Services
  • Subsidiaries & Ownership Structure
    Key Company Benchmarks

Why purchase access to Benchmarking Pro?

This profile on CH Boehringer Sohn AG & Ko. KG includes:

  • Company Overview
  • Company Revenue and Employee Data
  • Company Financial Statements
  • Industry Market Share Breakdown
  • Industry Competitor Matrix
  • SWOT Analysis
  • Products and Services
  • Key Company Benchmarks
  • Interconnected Competitor Profiles and Industry Reports
  • Full Access to Benchmarking Pro

The IBISWorld Benchmarking Pro solution enables you to:

  • Understand an enterprise’s competitive landscape and how they perform within a like-sized industry segment.
  • Benchmark companies against industry averages, segment averages and their competitors.
  • Identify real-world strengths, opportunities, weaknesses and threats for companies.
  • Target growth opportunities or spot red flags in a business growth strategy.
  • Toggle between company profiles and industry reports for a 360 degree view of a company's position.

IBISWorld provides profiles on thousands of leading companies around the world. Our clients rely on our information and data to stay up-to-date on business and industry trends across all sectors of the economy. This company profile, along with the corresponding competitor and industry data provided, includes thoroughly researched, reliable and current information that will help you to make faster, better business decisions.

Trusted by More Than 10,000 Clients Around the World

  • IBISWorld client - VISA
  • IBISWorld client - ADP
  • IBISWorld client - Deloitte
  • IBISWorld client - AMEX
  • IBISWorld client - Bank of Montreal